Cargando…

Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control

Infection with the human immunodeficiency virus (HIV), when left untreated, typically leads to disease progression towards acquired immunodeficiency syndrome. Some people living with HIV (PLWH) control their virus to levels below the limit of detection of standard viral load assays, without treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernard, Nicole F., Kant, Sanket, Kiani, Zahra, Tremblay, Cécile, Dupuy, Franck P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205404/
https://www.ncbi.nlm.nih.gov/pubmed/35720328
http://dx.doi.org/10.3389/fimmu.2022.879124
_version_ 1784729122987048960
author Bernard, Nicole F.
Kant, Sanket
Kiani, Zahra
Tremblay, Cécile
Dupuy, Franck P.
author_facet Bernard, Nicole F.
Kant, Sanket
Kiani, Zahra
Tremblay, Cécile
Dupuy, Franck P.
author_sort Bernard, Nicole F.
collection PubMed
description Infection with the human immunodeficiency virus (HIV), when left untreated, typically leads to disease progression towards acquired immunodeficiency syndrome. Some people living with HIV (PLWH) control their virus to levels below the limit of detection of standard viral load assays, without treatment. As such, they represent examples of a functional HIV cure. These individuals, called Elite Controllers (ECs), are rare, making up <1% of PLWH. Genome wide association studies mapped genes in the major histocompatibility complex (MHC) class I region as important in HIV control. ECs have potent virus specific CD8(+) T cell responses often restricted by protective MHC class I antigens. Natural Killer (NK) cells are innate immune cells whose activation state depends on the integration of activating and inhibitory signals arising from cell surface receptors interacting with their ligands on neighboring cells. Inhibitory NK cell receptors also use a subset of MHC class I antigens as ligands. This interaction educates NK cells, priming them to respond to HIV infected cell with reduced MHC class I antigen expression levels. NK cells can also be activated through the crosslinking of the activating NK cell receptor, CD16, which binds the fragment crystallizable portion of immunoglobulin G. This mode of activation confers NK cells with specificity to HIV infected cells when the antigen binding portion of CD16 bound immunoglobulin G recognizes HIV Envelope on infected cells. Here, we review the role of NK cells in antibody independent and antibody dependent HIV control.
format Online
Article
Text
id pubmed-9205404
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92054042022-06-18 Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control Bernard, Nicole F. Kant, Sanket Kiani, Zahra Tremblay, Cécile Dupuy, Franck P. Front Immunol Immunology Infection with the human immunodeficiency virus (HIV), when left untreated, typically leads to disease progression towards acquired immunodeficiency syndrome. Some people living with HIV (PLWH) control their virus to levels below the limit of detection of standard viral load assays, without treatment. As such, they represent examples of a functional HIV cure. These individuals, called Elite Controllers (ECs), are rare, making up <1% of PLWH. Genome wide association studies mapped genes in the major histocompatibility complex (MHC) class I region as important in HIV control. ECs have potent virus specific CD8(+) T cell responses often restricted by protective MHC class I antigens. Natural Killer (NK) cells are innate immune cells whose activation state depends on the integration of activating and inhibitory signals arising from cell surface receptors interacting with their ligands on neighboring cells. Inhibitory NK cell receptors also use a subset of MHC class I antigens as ligands. This interaction educates NK cells, priming them to respond to HIV infected cell with reduced MHC class I antigen expression levels. NK cells can also be activated through the crosslinking of the activating NK cell receptor, CD16, which binds the fragment crystallizable portion of immunoglobulin G. This mode of activation confers NK cells with specificity to HIV infected cells when the antigen binding portion of CD16 bound immunoglobulin G recognizes HIV Envelope on infected cells. Here, we review the role of NK cells in antibody independent and antibody dependent HIV control. Frontiers Media S.A. 2022-05-20 /pmc/articles/PMC9205404/ /pubmed/35720328 http://dx.doi.org/10.3389/fimmu.2022.879124 Text en Copyright © 2022 Bernard, Kant, Kiani, Tremblay and Dupuy https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Bernard, Nicole F.
Kant, Sanket
Kiani, Zahra
Tremblay, Cécile
Dupuy, Franck P.
Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control
title Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control
title_full Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control
title_fullStr Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control
title_full_unstemmed Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control
title_short Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control
title_sort natural killer cells in antibody independent and antibody dependent hiv control
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205404/
https://www.ncbi.nlm.nih.gov/pubmed/35720328
http://dx.doi.org/10.3389/fimmu.2022.879124
work_keys_str_mv AT bernardnicolef naturalkillercellsinantibodyindependentandantibodydependenthivcontrol
AT kantsanket naturalkillercellsinantibodyindependentandantibodydependenthivcontrol
AT kianizahra naturalkillercellsinantibodyindependentandantibodydependenthivcontrol
AT tremblaycecile naturalkillercellsinantibodyindependentandantibodydependenthivcontrol
AT dupuyfranckp naturalkillercellsinantibodyindependentandantibodydependenthivcontrol